$53.06
$0.00 (0.00%)
End-of-day quote: 05/10/2024
NasdaqGS:INCY
Incyte Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | NYSE | Outperform | $130.06 | $130.51 | 0.00% | 11 | $329.42B |
| ABBV | AbbVie | NYSE | Outperform | $160.75 | $178.42 | 0.00% | 11 | $283.86B |
| AZN | AstraZeneca PLC | LSE | Outperform | £123.70 | £165.99 | 0.00% | 16 | £191.76B |
| NOVN | Novartis | SWX | Hold | CHF92.32 | CHF105.00 | 0.00% | 9 | CHF188.37B |
| ROG | Roche Holding | SWX | Hold | CHF225.10 | CHF307.83 | 0.00% | 9 | CHF181.77B |
| AMGN | Amgen | NasdaqGS | Outperform | $310.15 | $303.65 | 0.00% | 8 | $166.38B |
| SAN | Sanofi | ENXTPA | Outperform | 94.33€ | 102.80€ | 0.00% | 9 | 117.78€B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $973.80 | $961.26 | 0.00% | 8 | $105.06B |
| GSK | GSK | LSE | Outperform | £18.00 | £17.30 | 0.00% | 12 | £73.38B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $44.94 | $58.15 | 0.00% | 10 | $91.10B |
| MRK | Merck KGaA | XTRA | Outperform | 155.50€ | 190.06€ | 0.00% | 4 | 67.61€B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.48T |
| 4523 | Eisai | TSE | Outperform | ¥6.79k | ¥9.58k | 0.00% | 0 | ¥1.95T |
| JAZZ | Jazz Pharmaceuticals | NasdaqGS | Outperform | $109.63 | $188.32 | 0.00% | 4 | $7.13B |
| EXEL | Exelixis | NasdaqGS | Outperform | $21.37 | $26.44 | 0.00% | 5 | $6.34B |
| IONS | Ionis Pharmaceuticals | NasdaqGS | Outperform | $39.08 | $55.60 | 0.00% | 3 | $5.76B |
| APLS | Apellis Pharmaceuticals | NasdaqGS | Outperform | $41.99 | $79.81 | 0.00% | 3 | $5.16B |
| MOR | MorphoSys | XTRA | Hold | 67.00€ | 28.78€ | 0.00% | 3 | 2.52€B |
| GERN | Geron | NasdaqGS | Outperform | $3.80 | $4.83 | 0.00% | 1 | $2.30B |
| PGEN | Precigen | NasdaqGS | Outperform | $1.27 | $9.46 | 0.00% | 2 | $325.62M |
| OMER | Omeros | NasdaqGM | Hold | $3.51 | $13.00 | 0.00% | 2 | $204.54M |
| XFOR | X4 Pharmaceuticals | NasdaqCM | Outperform | $1.05 | $3.26 | 0.00% | 1 | $183.05M |
| KPTI | Karyopharm Therapeutics | NasdaqGS | Outperform | $1.09 | $6.00 | 0.00% | 1 | $118.80M |
| DXB | Dimerix | ASX | $0.33 | $0.00 | 0.00% | 0 | $159.38M | |
| BLRX | BioLineRx | TASE | - | ₪0.16 | ₪1.39 | 0.00% | 0 | ₪302.07M |
| IFRX | InflaRx N.V. | NasdaqGS | Outperform | $1.18 | $9.44 | 0.00% | 2 | $70.66M |
| AKTX | Akari Therapeutics, Plc | NasdaqCM | - | $1.60 | $80.00 | 0.00% | 0 | $9.39M |
